Financial Contrast: SBC Medical Group (NASDAQ:SBC) vs. Medpace (NASDAQ:MEDP)

Medpace (NASDAQ:MEDP) and SBC Medical Group (NASDAQ:SBC) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, analyst recommendations, profitability, earnings and risk.

Earnings and Valuation

This table compares Medpace and SBC Medical Group”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medpace	$2.11 billion	7.59	$404.39 million	$14.30	39.75
SBC Medical Group	$205.42 million	2.26	$46.61 million	$0.41	11.02

Medpace has higher revenue and earnings than SBC Medical Group. SBC Medical Group is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Medpace and SBC Medical Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Medpace	18.36%	91.88%	23.65%
SBC Medical Group	24.28%	24.17%	18.60%

Analyst Ratings

This is a breakdown of current ratings for Medpace and SBC Medical Group, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medpace	4	10	2	1	2.00
SBC Medical Group	1	0	1	0	2.00

Medpace presently has a consensus price target of $490.82, indicating a potential downside of 13.64%. SBC Medical Group has a consensus price target of $9.00, indicating a potential upside of 99.12%. Given SBC Medical Group’s higher possible upside, analysts clearly believe SBC Medical Group is more favorable than Medpace.

Risk and Volatility

Medpace has a beta of 1.43, meaning that its share price is 43% more volatile than the S&P 500. Comparatively, SBC Medical Group has a beta of 1.23, meaning that its share price is 23% more volatile than the S&P 500.

Insider and Institutional Ownership

78.0% of Medpace shares are held by institutional investors. Comparatively, 60.8% of SBC Medical Group shares are held by institutional investors. 20.3% of Medpace shares are held by company insiders. Comparatively, 89.5% of SBC Medical Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Medpace beats SBC Medical Group on 11 of the 14 factors compared between the two stocks.

About Medpace

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

About SBC Medical Group

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand. SBC Medical Group Holdings Incorporated, formerly known as Pono Capital Two Inc., is based in TOKYO.